Literature DB >> 16250254

Pharmacokinetics of TJ-8117(Onpi-to), a drug for renal failure (II): effects of food, repeated administration and renal failure to plasma concentration of [3H]-(-)epicatechin 3-O-gallate in rats.

Yukiho Takizawa1, Toshimi Morita, Naoki Fujitsuka, Akiko Kido, Shouichirou Shindou, Hiroki Tomisawa, Yoshio Kase, Shuichi Takeda, Masaki Aburada, Keńtchi Miyamoto.   

Abstract

TJ-8117 (Onpi-to) is a herbal medicine extracted from mixture of five crude drugs (Rhei Rhizoma, Glycyrrhizae Radix, Ginseng Radix, Zingiberis Rhizoma and Aconiti Tuber), which has been developed as a drug for chronic renal failure. (-)Epicatechin 3-O-gallate (ECG), one of the active compounds of TJ-8117, was labeled with tritium and spiked to TJ-8117. Effects of food, renal failure and repeated administration to pharmacokinetics of ECG-related radioactivity in the plasma were investigated after oral administration of TJ-8117 containing [3H]ECG ([3H]TJ-8117) in male rats. After oral administration of [3H]TJ-8117, the radioactivity in the plasma in non-fasted rats was higher than that in fasted rats. AUC(0-72 h) and Cmax in the non-fasted was 123% and 248% of those in the fasted. After oral administration of [3H]TJ-8117, the radioactivity in the plasma in 5/6 nephrectomized rats was higher than that in sham-operated rats. AUC(0-72 h) and Cmax in 5/6 nephrectomized was 332% and 236% of those in sham-operated. After repeated administration of TJ-8117 for 6 days, [3H]TJ-8117 was administered on 7th day. Radioactivity in plasma in first day was similar to that in 7th day. The pharmacokinetic parameters were not significantly different between single and repeated administration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16250254     DOI: 10.1007/BF03190617

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  22 in total

1.  Biotransformation of (-)-epicatechin 3-O-gallate by human intestinal bacteria.

Authors:  M R Meselhy; N Nakamura; M Hattori
Journal:  Chem Pharm Bull (Tokyo)       Date:  1997-05       Impact factor: 1.645

2.  [Rhubarb therapy in patients with chronic renal failure (Part 2)].

Authors:  T Mitsuma; T Yokozawa; H Oura; K Terasawa
Journal:  Nihon Jinzo Gakkai Shi       Date:  1987-02

3.  [Effects of Onpi-to (TJ-8117) on mesangial injury induced by anti Thy-1 antibody].

Authors:  T Hattori; S Shindo; T Hisada; N Fujitsuka; T Hibino; Y Terazono; M Maruno
Journal:  Nihon Yakurigaku Zasshi       Date:  1995-02

4.  Effects of rhubarb tannins on renal function in rats with renal failure.

Authors:  T Yokozawa; K Fujioka; H Oura; G Nonaka; I Nishioka
Journal:  Nihon Jinzo Gakkai Shi       Date:  1993-01

5.  Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols.

Authors:  S Kim; M J Lee; J Hong; C Li; T J Smith; G Y Yang; D N Seril; C S Yang
Journal:  Nutr Cancer       Date:  2000       Impact factor: 2.900

6.  [Effects of onpi-to (TJ-8117) and (-)epicatechin-3-O-gallate on the proliferating changes in glomeruli of 5/6 nephrectomized rats].

Authors:  N Fujitsuka; A Kurogi; T Hattori; S Shindo
Journal:  Nihon Jinzo Gakkai Shi       Date:  1997-10

7.  [Effect of Onpi-to (TJ-8117) on TGF-beta 1 in rats with 5/6 nephrectomized chronic renal failure].

Authors:  T Hattori; N Fujitsuka; A Kurogi; S Shindo
Journal:  Nihon Jinzo Gakkai Shi       Date:  1996-11

8.  Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue.

Authors:  M Suganuma; S Okabe; M Oniyama; Y Tada; H Ito; H Fujiki
Journal:  Carcinogenesis       Date:  1998-10       Impact factor: 4.944

9.  Effects of rhubarb tannins on uremic toxins.

Authors:  T Yokozawa; K Fujioka; H Oura; G Nonaka; I Nishioka
Journal:  Nephron       Date:  1991       Impact factor: 2.847

10.  Studies on flavonoid metabolism. Metabolism of (+)-[14C] catechin in the rat and guinea pig.

Authors:  N P Das; L A Griffiths
Journal:  Biochem J       Date:  1969-12       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.